Sigma Planning Corp’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $450K | Sell |
|
|||||
|
2024
Q3 | $1.18M | Buy |
|
|||||
|
2024
Q2 | $755K | Sell |
|
|||||
|
2024
Q1 | $2.14M | Buy |
|
|||||
|
2023
Q4 | $443K | Sell |
|
|||||
|
2023
Q3 | $750K | Sell |
|
|||||
|
2023
Q2 | $893K | Sell |
|
|||||
|
2023
Q1 | $944K | Sell |
|
|||||
|
2022
Q4 | $1.07M | Sell |
|
|||||
|
2022
Q3 | $1.07M | Sell |
|
|||||
|
2022
Q2 | $1.27M | Buy |
|
|||||
|
2022
Q1 | $1.36M | Buy |
|
|||||
|
2021
Q4 | $1.11M | Buy |
|
|||||
|
2021
Q3 | $1.14M | Sell |
|
|||||
|
2021
Q2 | $1.33M | Buy |
|
|||||
|
2021
Q1 | $1.06M | Sell |
|
|||||
|
2020
Q4 | $1.53M | Buy |
|
|||||
|
2020
Q3 | $865K | Sell |
|
|||||
|
2020
Q2 | $2.07M | Sell |
|
|||||
|
2020
Q1 | $1.54M | Buy |
|
|||||
|
2019
Q4 | $1.8M | Sell |
|
|||||
|
2019
Q3 | $1.64M | Buy |
|
|||||
|
2019
Q2 | $1.88M | Buy |
|
|||||
|
2019
Q1 | $1.55M | Buy |
|
|||||
|
2018
Q4 | $567K | Sell |
|
|||||
|
2018
Q3 | $849K | Sell |
|
|||||
|
2018
Q2 | $874K | Sell |
|
|||||
|
2018
Q1 | $848K | Sell |
|
|||||
|
2017
Q4 | $847K | Buy |
|
|||||
|
2017
Q3 | $858K | Buy |
|
|||||
|
2017
Q2 | $698K | Buy |
|
|||||
|
2017
Q1 | $497K | Sell |
|
|||||
|
2016
Q4 | $557K | Sell |
|
|||||
|
2016
Q3 | $836K | Buy |
|
|||||
|
2016
Q2 | $657K | Buy |
|
|||||
|
2016
Q1 | $353K | Sell |
|
|||||
|
2015
Q4 | $481K | Sell |
|
|||||
|
2015
Q3 | $439K | Sell |
|
|||||
|
2015
Q2 | $604K | Buy |
|
|||||
|
2015
Q1 | $535K | Buy |
|
|||||
|
2014
Q4 | $340K | Buy |
|